Incorporation of transradial approach in neuroendovascular procedures: defining benchmarks for rates of complications and conversion to femoral access.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 08 02 2020
revised: 04 03 2020
accepted: 11 03 2020
pubmed: 29 3 2020
medline: 27 1 2021
entrez: 29 3 2020
Statut: ppublish

Résumé

The transradial approach (TRA) has gained increasing popularity for neuroendovascular procedures. However, the experience with TRA in neuroangiography is still in early stages in most centers, and the safety and feasibility of this approach have not been well established. The purpose of this study is to report the safety and feasibility of TRA for neuroendovascular procedures. We reviewed charts from six institutions in the USA to include consecutive patients who underwent diagnostic or interventional neuroendovascular procedures through TRA from July 2018 to July 2019. Collected data included baseline characteristics, procedural variables, complications, and whether there was a crossover to transfemoral access. A total of 2203 patients were included in the study (age 56.1±15.2, 60.8% women). Of these, 1697 (77%) patients underwent diagnostic procedures and 506 (23%) underwent interventional procedures. Successfully completed procedures included aneurysm coiling (n=97), flow diversion (n=89), stent-assisted coiling (n=57), balloon-assisted coiling (n=19), and stroke thrombectomy (n=76). Crossover to femoral access was required in 114 (5.2%). There were no major complications related to the radial access site. Minor complications related to access site were seen in 14 (0.6%) patients. In this early stage of transforming to the 'radial-first' approach for neuroendovascular procedures, TRA was safe with low complication rates for both diagnostic and interventional procedures. A wide range of procedures were completed successfully using TRA.

Sections du résumé

BACKGROUND BACKGROUND
The transradial approach (TRA) has gained increasing popularity for neuroendovascular procedures. However, the experience with TRA in neuroangiography is still in early stages in most centers, and the safety and feasibility of this approach have not been well established. The purpose of this study is to report the safety and feasibility of TRA for neuroendovascular procedures.
METHODS METHODS
We reviewed charts from six institutions in the USA to include consecutive patients who underwent diagnostic or interventional neuroendovascular procedures through TRA from July 2018 to July 2019. Collected data included baseline characteristics, procedural variables, complications, and whether there was a crossover to transfemoral access.
RESULTS RESULTS
A total of 2203 patients were included in the study (age 56.1±15.2, 60.8% women). Of these, 1697 (77%) patients underwent diagnostic procedures and 506 (23%) underwent interventional procedures. Successfully completed procedures included aneurysm coiling (n=97), flow diversion (n=89), stent-assisted coiling (n=57), balloon-assisted coiling (n=19), and stroke thrombectomy (n=76). Crossover to femoral access was required in 114 (5.2%). There were no major complications related to the radial access site. Minor complications related to access site were seen in 14 (0.6%) patients.
CONCLUSION CONCLUSIONS
In this early stage of transforming to the 'radial-first' approach for neuroendovascular procedures, TRA was safe with low complication rates for both diagnostic and interventional procedures. A wide range of procedures were completed successfully using TRA.

Identifiants

pubmed: 32217626
pii: neurintsurg-2020-015893
doi: 10.1136/neurintsurg-2020-015893
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1122-1126

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Auteurs

Eyad Almallouhi (E)

Neurology, Medical University of South Carolina, Charleston, South Carolina, USA.

Sami Al Kasab (S)

Neurology, Medical University of South Carolina, Charleston, South Carolina, USA.
Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Mithun G Sattur (MG)

Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Jonathan Lena (J)

Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Pascal M Jabbour (PM)

Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Ahmad Sweid (A)

Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Nohra Chalouhi (N)

Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

M Reid Gooch (MR)

Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Robert M Starke (RM)

Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Eric C Peterson (EC)

Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Dileep R Yavagal (DR)

Neurology and Neurosurgery, University of Miami, Miami, Florida, USA.

Stephanie H Chen (SH)

Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Yangchun Li (Y)

Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Bradley A Gross (BA)

Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Daniel A Tonetti (DA)

Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Benjamin M Zussman (BM)

Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Jeremy G Stone (JG)

Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Ashutosh P Jadhav (AP)

Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Brian T Jankowitz (BT)

Neurosurgery, Cooper Neurological Institute, Camden, New Jersey, USA.

Christopher C Young (CC)

Neurological Surgery, University of Washington, Seattle, Washington, USA.

Do H Lim (DH)

Neurological Surgery, University of Washington, Seattle, Washington, USA.

Michael R Levitt (MR)

Neurological Surgery, Radiology and Mechanical Engineering, University of Washington, Seattle, Washington, USA.

Joshua W Osbun (JW)

Neurosurgery, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA.

Alejandro M Spiotta (AM)

Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA spiotta@musc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH